[1]
V. P. K. Gopinath, B. A. Kolaparambath, V. M. Simi, C. M. A. Rishad, P. M. Farisa, and T. Jose, “Rituximab as first line: an advent in pemphigus”, Int J Res Dermatol, vol. 5, no. 1, pp. 212–216, Jan. 2019.